ANTAGONISTAS DEL RECEPTOR HISTAMINA H3.

摘要

Un compuesto seleccionado entre: 5-(4-clorofenil)-2-(4-isopropilpiperacin-1-il)pirimidina; 2-(4-isopropilpiperacin-1-il)-5-(4-trifluorometilfenil)pirimidina; 4-[2-(4-isopropilpiperacin-1-5 il)pirimidin-5-il]benzonitrilo; 5-(4-fluorofenil)-2-(4-isopropilpiperacin-1-il)pirimidina; 2-(4-isopropilpiperacin-1-il)-5-(4-trifluorometoxilfenil)pirimidina; 2-(4-isopropilpiperacin-1-il)-5-(4-metoxilfenil)pirimidina; 4-[2-(4-isopropilpiperacin-1-il)pirimidin-5-il]benzonitrilo; N-{4-[2-(4-isopropilpiperacin-1-il)pirimidin-5-il]bencil}acetamida; {4-[2-(4-isopropilpiperacin-1-il)pirimidin-6-il]fenil}acetonitrilo; N-{4-[2-(4-isopropilpiperacin-1-il)pirimidin-5-il]fenil}acetamida; 1-{4-[2-(4-isopropilpiperacin-1-il)pirimidin-5-il]fenil}etanona; 2-(4-isopropilpiperacin-1-il)-5-piridin-3-ilpirimidina; 2-(4-isopropilpiperacin-1-il)-5-piridin-4-ilpirimidina; {4-[2-(4-isopropilpiperacin-1-il)pirimidin-5-il]fenil}dimetilamina; 3-[2-(4-isopropilpiperacin-1-il)pirimidin-5-il]-N,N-dimetilbenzamida; 4-{4-[2-(4-ciclopropilpiperacin-1-il)pirimidin-5-il]bencil}morfolina; N-{4-[2-(4-isopropilpiperacin-1-il)pirimidin-5-il]bencil}isobutiramida; 4-[2-(4-ciclopropilpiperacin-1-il)pirimidin-5-il]bencilamina; y N-{4-[2-(4-ciclopropilpiperacin-1-il)pirimidin-5-il]bencil}acetamida; o una sal o solvato aceptable farmacéuticamente de las mismas.